Contributors

Contributors Samuel S. Myers and Aaron Bernstein are interested in the bigger picture. Both enrolled in interdisciplinary programs in college and moved on to medical school. But even their medical school and residency experiences were untraditional. Myers enlarged his view of the world by taking a two-year break from his medical residency at the University of California, San Francisco, when Tibetan officials invited him to become the health administrator of Qomolangm

Written byThe Scientist
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Samuel S. Myers and Aaron Bernstein are interested in the bigger picture. Both enrolled in interdisciplinary programs in college and moved on to medical school. But even their medical school and residency experiences were untraditional. Myers enlarged his view of the world by taking a two-year break from his medical residency at the University of California, San Francisco, when Tibetan officials invited him to become the health administrator of Qomolangma (Everest) National Park. There he taught basic health care and conservation practices to villagers living within the national park. Now an instructor and doctor at Harvard Medical School, Myers studies the effect of climate change on human health. Bernstein attended the University of Chicago’s medical school program, which, unlike any others at the time, integrated its medical school with its division of biological sciences. “I would often take classes with people getting PhDs in cell biology,” he says. Now a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies